Metraipolis › archive › dc_7a7aafeff56c

Real-world efficacy and safety of anlotinib in Chinese solid tumors patients with liver metastases: a multicenter retrospective study — Europe PMC PMID:42222141

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42222141
DOI
10.3389/fphar.2026.1639934
License (as archived)
solo-consultazione
Archived
2026-11-01T17:13:31.582Z
SHA-256 of the archived text
28f421b5a0f08a5f1a0366cc99b71b15128995bc03d6c974aa11ce84f9ad23ad
Stable URL of this page
https://metraipolis.com/documento/dc_7a7aafeff56c

How to cite

Real-world efficacy and safety of anlotinib in Chinese solid tumors patients with liver metastases: a multicenter retrospective study — Europe PMC PMID:42222141 — Europe PMC (en), https://europepmc.org/article/MED/42222141 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7a7aafeff56c (Metraipolis archive dc_7a7aafeff56c, sha256 28f421b5a0f08a5f1a0366cc99b71b15128995bc03d6c974aa11ce84f9ad23ad)
BibTeX
@misc{dc7a7aafeff56c,
  title = {Real-world efficacy and safety of anlotinib in Chinese solid tumors patients with liver metastases: a multicenter retrospective study — Europe PMC PMID:42222141},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42222141},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7a7aafeff56c; sha256 28f421b5a0f08a5f1a0366cc99b71b15128995bc03d6c974aa11ce84f9ad23ad},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42222141. Agents can read the archived copy with the MCP tool read_document.